Reporting for the family-office world.

An Exclusive Behind-The-Scenes Look at Avisa Diagnostics Inc.’s Innovation We invite you to join us for an exclusive look at Avisa Diagnostics’ innovative platform and how it is transforming healthcare. Avisa is a clinical-stage medical device company developing the Avisa BreathTest™, (ABT), a novel drug/device combination biomarker technology platform. The Company has established clinical proof-of-concept through trials in cystic fibrosis, tuberculosis and community-acquired pneumonia, which demonstrated positive safety and clinical efficacy results. There are 1.7 million patients on ventilators annually in the U.S, with 400,000 of these patients diagnosed with ventilator-associated pneumonia, resulting in a mortality rate of 30% to 50%.

Join Our Exclusive Family Office Investor Event to learn more about Arterez. Cardiovascular Disease (CVD) is the world’s leading chronic killer impacting more than one-third of the world’s population. US direct and indirect healthcare costs due to CVD is expected to grow to an estimated $1.5 trillion by 2030. Among the top 150 developing nations worldwide, CVD is the largest health risk and cost. Dr. J.B. Tunac and Arterez believe they have discovered the multi-factorial root causes of chronic vascular disease and that those can be identified, characterized, cured and ultimately prevented. The company’s first drug, Embotricin™, targets healing at the cellular level rather than targeting symptoms. The company has also developed a biomarker panel for treatment monitoring, known as GlycoCardia™ that can also be used for disease identification, staging and classification. Embotricin™ proved to prevent and reverse arterial plaques in models and proved non-toxic up to 300x the effective dose. First in-human studies are expected to begin Q1 2023.

Join Leading Family Offices for a Deep Dive into Corporate Security Solutions, Inc. The Corporate Security Solutions team is led by licensed private investigator John Glavin who has 30+ years of experience helping family offices and leading corporations handle complex security requirements. Services include corporate investigations, litigation and legal disputes, due diligence, risk analysis and threat, family issues related to divorce and other domestic issues, background checks, business investigation, cybersecurity, insurance, EEOC, sexual harassment claims, and related matters

Join Our Exclusive Family Office Networks Investor Event to learn more about Estonia. Estonia is the #1 country in billion-dollar companies (“unicorns”) founded per capita in Europe and #2 globally and leads Europe in the founding of new tech startups. For the last 5 years, its startup sector has grown 30% YoY, whether measured by revenues, jobs created, or fundraising. This trajectory will result in 30% of Estonia’s GDP coming from the tech sector by 2030. During the webinar, you will learn how family offices can participate in Estonia’s exciting and vibrant startup sector.